Stock Updates

How has Gilead Sciences Inc.:(NASDAQ:GILD) performed recently?

Gilead Sciences Inc. (NASDAQ: GILD) is a large market cap stock with a market cap of 120224.19. It is in the Biotechnology industry and sector Healthcare, with a current P/E of 7.44, a forward P/E of 7.06 and EPS of 11.69. At a stock price of 85.87 (-1.21%) it has a dividend yield of 2.16%.

EPS growth for the last five years have been 48.30%, more recently this last year it has grown by 62.00%. The next year growth is going to be about 2.14% and more long-term 0.79% after five years. EPS growth quarter over quarter is -8.60%. Sales growth for the past five years have been 32.60% and sales growth quarter over quarter is 2.60%.

For performance, Gilead Sciences Inc. the past week has seen a gain of 0.79%. For the last month performance for Gilead Sciences Inc. is 4.10%. While the last quarter is -11.88% and half year, -4.35%. Finally for the year, performance is -25.11%.

The 52-week high for Gilead Sciences Inc., is at -27.31%, and for the 52-week low it comes to a value of 10.21%. The 20-day simple moving average is 1.93% and -7.74% for the 200-day simple moving average.

Volatility for the week is at 1.57%, and for the month it is 2.11%. Gilead Sciences Inc., has a target price of 110.58.

In terms of debt, long term debt/equity is 1.57, and for total debt/equity Gilead Sciences Inc. has 1.7. The gross margin is 86.90%, while operating margin is 65.40%, the profit margin is 52.80%. The current ratio is 1.8 and the quick ratio is 1.6.

Insider ownership is at 0.50%, with instituitional ownership at 81.80%. Gilead Sciences Inc. has a payout ratio of 14.30%. With the total shares outstanding coming to 1383. The shares float is 1322.84, with the float short at 1.68%, with short ratio coming to 2.34.

In terms of returns, the return on assets see Gilead Sciences Inc., get 36.60%, with its returns on investment at 45.90%. Return on equity is 105.70%. So will the investors see the target price of 110.58, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Stephen Butters

Leave a Comment